|
ACAD8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.396600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.924370E-01 |
| Normal-vs-Stage2 |
6.483600E-02 |
| Normal-vs-Stage3 |
9.548000E-02 |
| Normal-vs-Stage4 |
4.284500E-02 |
| Stage1-vs-Stage2 |
9.704800E-03 |
| Stage1-vs-Stage3 |
5.539400E-01 |
| Stage1-vs-Stage4 |
2.697600E-01 |
| Stage2-vs-Stage3 |
5.318700E-03 |
| Stage2-vs-Stage4 |
2.555900E-03 |
| Stage3-vs-Stage4 |
5.122200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.621700E-02 |
| Normal-vs-AfricanAmerican |
5.994000E-01 |
| Normal-vs-Asian |
6.212200E-02 |
| Caucasian-vs-AfricanAmerican |
7.010400E-01 |
| Caucasian-vs-Asian |
4.995600E-01 |
| AfricanAmerican-vs-Asian |
4.337200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.364400E-02 |
| Normal-vs-Female |
4.623200E-01 |
| Male-vs-Female |
1.333980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.330100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.717200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.016600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.144400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.619800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.761200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.398810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.294000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.280200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.576400E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.267200E-01 |
| Classical-VS-Follicular |
5.85970000299696E-08 |
| Classical-VS-Other |
9.608600E-01 |
| Classical-VS-Normal |
1.897480E-03 |
| Tall-VS-Follicular |
1.7912999972225E-08 |
| Tall-VS-Other |
6.018400E-01 |
| Tall-VS-Normal |
1.239500E-03 |
| Follicular-VS-Other |
1.158540E-03 |
| Follicular-VS-Normal |
6.635200E-04 |
| Other-VS-Normal |
1.694390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.952000E-01 |
| Normal-vs-N1 |
1.444450E-03 |
| N0-vs-N1 |
2.446200E-04 |
|
|
